Using data from a large nationwide network of community-based health organizations, new study highlights critical shortfalls in cancer prevention care among patients who experience social and economic ...
Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast, according to 6-year data from the OlympiA trial.
Rachel Reid, head coach of he Lagan Dragons, says she is "privileged" after being named as BBC Sport NI's Unsung Hero for 2024 for her work with those impacted by breast cancer.
For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of recurrence in the ...